Novartis said its second-quarter profit fell 32% from the same period last year, as the Swiss drug giant was hit by a strengthened dollar and a weak result from its eye-care treatment business.
from WSJ.com: US Business http://ift.tt/1gLqx0P
via IFTTT
No comments:
Post a Comment